Fear of Covid-19 is delaying treatment for cancer patients, leading to complications and a lower survival rate In cancer, timely diagnosis is essential. It allows the disease to be identified at a treatable stage and prevents complications. But since the emergence of the coronavirus disease, the diagnosis and treatment of cancer has been negatively impacted. …
A father-of-five has warned of the devastating financial impact of his cancer diagnosis. Doug Harper, 58, from Plumstead, was found to have stage two breast cancer in January 2012 after being made redundant, so struggled to make ends meet. Mr Harper found it hard to get by after the costs of travelling to hospital treatment …
Even those with health insurance needed help navigating the financial consequences of cancer treatment, study showed Multiple studies show that cancer care costs contribute to financial toxicity in patients undergoing treatment. Now, recent results from the SWOG S1417CD trial in patients with newly diagnosed metastatic colorectal cancer (mCRC) add to the evidence on how many patients are …
Maybe it’s not that surprising that a recent CDC study revealed that four of 10 US adults have put off regular medical care because of their COVID-19-related concerns. The study’s authors found that as of June 30, 41 percent of adults delayed or avoided medical care. This includes emergency care, urgent care and routine care. …
Cancer does not affect everyone in the same way. A combination of factors, including race, ethnicity, sexual orientation, or socioeconomic status can make some patients face a greater cancer burden and poorer outcomes in cancer care and treatment. These inequities are called cancer disparities. The causes “are complex and reflect social and economic disparities and …
A new analysis predicts close to 3000 additional deaths over a 10-year period in patients who faced delays in breast cancer treatment during the pandemic. The coronavirus disease 2019 (COVID-19) pandemic has caused widespread delays and cancellations in the health care world, including in cancer care. And for breast cancer patients facing delays in surgery, …
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to “purify” the immune cells of patients in the fight against cancer. UniSA’s Future Industries Institute PhD student Mona Elsemary has developed a microfluidic approach to purify chimeric antigen receptor (CAR-T) cells, the …
Karen Sock still remembers the day she found a lump under her right breast. “I made a couple of appointments to go to the doctor, and I canceled,” Sock said. More than 275,000 women in the U.S. will be diagnosed with breast cancer this year. The average treatment will cost anywhere between $20,000 and $100,000. https://www.cnbc.com/video/2020/10/22/how-much-it-costs-to-treat-breast-cancer.html Sock, …
Bertrand Levesque was having most of the cost of his cancer treatments picked up by Medicare, his son Roger said. Then the Newington resident in his eighties had a bad reaction to his chemotherapy shots and had to switch to oral chemotherapy which he takes at home. The transition, from going to a cancer center …
Financial hardship is linked with higher death risk, irrespective of an individual’s cancer history. These findings were presented at the 2020 American Society of Clinical Oncology (ASCO) Quality Care Symposium. People who have survived cancer are known to experience financial hardship in the United States. “Compared to individuals without a cancer history, cancer survivors have …